CLINICAL_TRIALS
trial_result
· 2011-10-12
Clinical Trial Update: Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms. [Phase 4]
Summary
Phase 4 trial evaluating Rizatriptan for acute treatment of migraine in patients with unilateral trigeminal-autonomic symptoms has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: IRCCS San Raffaele | Conditions: Migraine | Phase 4 | Status: COMPLETED